APA Citatie

Lehraiki, A., Cerezo, M., Rouaud, F., Abbe, P., Allegra, M., Kluza, J., . . . Rocchi, S. (2015). Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib. Cell Discov.

Chicago Style citaat

Lehraiki, Abdelali, et al. "Increased CD271 Expression By the NF-kB Pathway Promotes Melanoma Cell Survival and Drives Acquired Resistance to BRAF Inhibitor Vemurafenib." Cell Discov 2015.

MLA citatie

Lehraiki, Abdelali, et al. "Increased CD271 Expression By the NF-kB Pathway Promotes Melanoma Cell Survival and Drives Acquired Resistance to BRAF Inhibitor Vemurafenib." Cell Discov 2015.